What is the PASI Score?
The Psoriasis Area Severity Index (PASI) is a standardized scoring system designed to quantify the extent and severity of psoriasis. It provides a numerical value ranging from 0 to 72, where 0 indicates no visible signs of psoriasis and 72 represents severe involvement across all body areas.
Developed in the late 1980s by dermatologists, PASI is widely used in clinical trials for new treatments and as a tool for monitoring disease progression in individual patients.
Components of the PASI Score
The PASI score is calculated based on three main components: erythema (redness), desquamation (scaling or flaking), and thickness of plaques. Each component is scored independently, with a range from 0 to 6 for each body area, resulting in the total PASI score.
These scores are then weighted by the percentage of body surface area affected, leading to a final PASI value that reflects both the extent and severity of psoriasis.
Why It Matters
The PASI score is crucial for evaluating treatment efficacy in clinical studies. It allows researchers and clinicians to objectively measure changes over time, which is essential for determining the effectiveness of new therapies.
Moreover, it helps in managing patient care by providing a standardized method to track disease progression and response to therapy.
Real-World Applications
In clinical practice, PASI scores are used to guide treatment decisions. For instance, a significant reduction in the PASI score can indicate improvement or remission of psoriasis, while an increase may suggest disease flare-ups.
Additionally, it is employed in large-scale epidemiological studies to assess the prevalence and severity of psoriasis across different populations.
Frequently asked questions
How does PASI differ from other psoriasis scoring systems?
PASI combines three components (erythema, desquamation, and plaque thickness) with the percentage of body surface area affected, providing a more comprehensive assessment compared to simpler scoring methods like BSA or VAS.
Can PASI be used for all types of psoriasis?
PASI is primarily designed for chronic plaque psoriasis but can also be applied to other forms such as guttate, inverse, and pustular psoriasis with some modifications.
Is the PASI score subjective or objective?
While the scoring process involves visual assessment by a dermatologist, the PASI system standardizes this evaluation through specific criteria and guidelines to minimize subjectivity.
How often should PASI scores be reassessed in clinical trials?
PASI scores are typically reassessed every 4-8 weeks during clinical trials to monitor treatment efficacy, but the frequency can vary based on the study design and specific protocol guidelines.
Try it live
Everything above runs in your browser — open PASI Psoriasis Area Severity Index Calculator Simulator and change the parameters while it is running. Nothing is installed, nothing is uploaded, the whole model lives in one tab.
▶ Open PASI Psoriasis Area Severity Index Calculator Simulator simulation